The thyroid eye disease treatment market is estimated to be valued at US$ 1.40 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Thyroid eye disease, also known as Graves' ophthalmopathy, is an inflammatory eye condition associated with an overactive thyroid gland or Graves' disease. The condition causes muscles ... Read more
